Financings in Brief: U.S. Surgical
This article was originally published in The Gray Sheet
U.S. Surgical: Files registration statement with the Securities and Exchange Commission related to the proposed sale of up to $200 mil. in debt securities, shares of preferred stock, common stock and the warrants to purchase them. The securities may be offered "from time to time, together or separately," the filing states. Proceeds will go toward general corporate purposes...
You may also be interested in...
Previous businesses FDA warned about COVID-19 claims for chlorine dioxide, a bleach solution, were marketing dietary supplements unlawfully. But Pro Breath MD's oral rinses available under the Dentist Select and OraCare brands are allowed and FDA isn’t asking the firm to discontinue distribution.
The Stark Law ban on self-referrals wouldn’t apply to some physician owners of advanced imaging facilities under a CMS final rule.
Pfizer’s abrocitinib and Biogen/Eisai’s aducanumab are among a host of new investigational products that are under review by the European Medicines Agency.